Clinical trial
Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients
NCT01656213 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- July 31, 2014
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, stroke